American Society of Clinical Oncology

SHERPA: White

People

  1. Postow
    Postow
  2. Coit
    Coit
  3. Shoushtari
    Shoushtari
  4. Panageas
    Panageas
  5. Busam
    Busam
  6. Momtaz
    Momtaz
  7. Strong
    Strong
  8. Brady
    Brady
  9. Brennan
    Brennan
  10. Ariyan
    Ariyan

Groups

  1. Melanoma Disease Management Team (273)
  2. Department of Medicine (203)
  3. Solid Tumor Oncology Division (189)
  4. Melanoma and Immunotherapeutics Service (143)
  5. Survivorship Research (113)
  6. Hematologic Malignancies, Division of (106)
  7. Surgery (101)
  8. GSK Faculty (91)
  9. Epidemiology and Biostatistics (87)
  10. Biostatistics Service (78)
Search Within
  1. "Melanoma Disease Management Team"
Formats
  1. Meeting Abstract (194)
  2. Journal Article (74)
  3. Editorial (3)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Melanoma Disease Management Team (273)
  2. Department of Medicine (203)
  3. Solid Tumor Oncology Division (189)
  4. Melanoma and Immunotherapeutics Service (143)
  5. Survivorship Research (113)
  6. Hematologic Malignancies, Division of (106)

More Groups

People
  1. Michael Postow (82)
  2. Daniel Coit (65)
  3. Alexander Shoushtari (63)
  4. Jedd Wolchok (59)
  5. Margaret Callahan (38)
  6. Paul Chapman (38)

More People

Years
  1. 2024 (1)
  2. 2023 (19)
  3. 2022 (14)
  4. 2021 (17)
  5. 2020 (12)
  6. 2019 (21)

More Years

Publications
  1. Journal of Clinical Oncology (263)
  2. JCO Precision Oncology (6)
  3. American Society of Clinical Oncology Educational Book (3)
  4. Journal of Oncology Practice (1)

Results (273)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checkpoint inhibitor (CPI) experienced patients (pts) from COSMUS-1: A clinical observational study of talimogene laherparepvec (T-VEC) in United States practice
    Meeting Abstract

    Perez, M.; Amatruda, T.; Conry, R. M.; Ariyan, C. E.; Desai, A. M.; Kirkwood, J. M.; Treichel, S.; Ismail, R.; Raskin, L.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Treatment outcomes of immune-related cutaneous adverse events
    Journal Article

    Phillips, G. S.; Wu, J.; Hellmann, M. D.; Postow, M. A.; Rizvi, N. A.; Freites-Martinez, A.; Chan, D.; Dusza, S.; Motzer, R. J.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer statement
    Guidelines

    Tsimberidou, A. M.; Levit, L. A.; Schilsky, R. L.; Averbuch, S. D.; Chen, D.; Kirkwood, J. M.; McShane, L. M.; Sharon, E.; Mileham, K. F.; Postow, M. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clonal evolution of uveal melanoma metastases
    Meeting Abstract

    Yang, J.; Geiger, H. M.; Zhao, J.; Chen, J. C.; Arora, K.; Shah, M.; Fabius, A.; Cavatore, M.; Kandoth, C.; Merghoub, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors
    Meeting Abstract

    Sullivan, R. J.; Hong, D. S.; Tolcher, A. W.; Patnaik, A.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L. H.; Roberts, J.; Lee, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Treatment of metastatic human papillomavirus-associated epithelial cancers with adoptive transfer of tumor-infiltrating T cells
    Meeting Abstract

    Stevanovic, S.; Helman, S. R.; Wunderlich, J. R.; Langhan, M. M.; Doran, S. L.; Kwong, M. L. M.; Somerville, R. P.; Klebanoff, C. A.; Kammula, U.; Sherry, R. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Shoushtari, A. N.; Armenia, J.; Arora, A.; Rojas-Zamalloa, J.; Warner, A. B.; Derr, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Coit, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma
    Meeting Abstract

    Shoushtari, A. N.; Freeman, M. L.; Betts, K. A.; Gupte-Singh, K.; Du, E. X.; Ritchings, C.; Rao, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save